Rimonabant is the first selective CB1 receptor blocker to be approved for use anywhere in the world. In Europe, it is indicated for use in conjunction with diet and exercise for patients with a body mass index greater than 30 kg/m², or patients with a BMI greater than 27 kg/m² with associated risk factors, such as type 2 diabetes or dyslipidaemia. In the UK, it has been available since the end of July 2006. As of 2008, the drug was available in 56 countries.

 

You should not take RIMONABANT if you have ever been addicted to drugs or alcohol, if you are currently intoxicated (drunk), or if you have recently used any of the following drugs:

 

- alcohol;
- narcotic pain medicine;
- sedatives or tranquilizers (such as Valium);
- medicine for depression or anxiety;
- medicine for mental illness (such as bipolar disorder, schizophrenia); or street drugs.

 

Seizures have occurred in some people taking RIMONABANT. Your risk of a seizure may be higher if you have any of these conditions:

 

- a history of drug or alcohol addiction;
- a history of epilepsy or other seizure disorder;
- a history of head injury;
- a metabolic disorder; or
- if you are also taking an antidepressant, muscle relaxer, or medicine for nausea and vomiting.

- Talk with your doctor about your individual risk of having a seizure while taking RIMONABANT.

 

Before taking RIMONABANT, tell your doctor if you are allergic to any drugs, or if you have:

 

- kidney disease;
- liver disease;
- a stomach disorder; or
- a history of depression, mental illness, or suicide attempt.

 

If you have any of these conditions, you may need a dose adjustment or special tests to safely take RIMONABANT.
FDA pregnancy category C. This medication may be harmful to an unborn baby. RIMONABANT may also cause serious or fatal side effects in a newborn if the mother uses the medication during pregnancy or labor. Tell your doctor if you are pregnant or plan to become pregnant during treatment. RIMONABANT can pass into breast milk and may harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby. RIMONABANT should not be given to a child younger than 18 years of age.

 

Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the medicine at the next regularly scheduled time. Do not take extra medicine to make up the missed dose.

 

As is common with many medications, users of Rimonabant may experience some side effects whilst taking the drug. A list of recorded side effects is given below:

More commonly reported:

 

- nausea
- dizziness
- headache
- diarrhea

 

Less commonly reported:

 

- anxiety
- depressed mood
- depression
- vomiting
- insomnia
- paresthesia (pins and needles)
- tremor
- somnolence (drowsiness)
- amnesia
- disturbance in attention

 

Concerns have been raised by the EMDAC (Endocrinologic and Metabolic Drugs Advisory Committee) about the prevalence of cases of psychiatric disorders that occurred within members of the test study groups who were taking Rimonabant. Notably, suicide was committed by two participants of the Rimonabant trials who had been taking the drug.

 

Acomplia is available in two doses, 10 and 20 mg's. The 20 mg dose is far more commonly prescribed, and is likely the dose you would take daily.

 

The Acomplia dosage regimen is easy to follow. Take a single 20 mg Acomplia pill first thing in the morning, with a full glass of water. Acomplia must be taken on an empty stomach to be effective, so most doctors will recommend that you refrain from eating breakfast for an hour after taking the medication.

 

If you forget a pill, you should take it again as soon as you remember. You should never double your dosage, as this will not cause increased weight loss, and could be harmful.

 

It is also important to speak with your doctor about any and all other medications that you are taking. Acomplia is a very safe drug, but this full disclosure will ensure that you don't have any adverse reactions.

 

Some people experience some minor side effects at the beginning of a period of treatment with Acomplia. These side effects are not serious, and will lessen in severity with time as your body gets more accustomed to the medication.

 

If you are obese, (a BMI score of 30 or more) you should consider therapeutic treatment with Acomplia rimonabant. Acomplia may give you the strength you need to stick with a sensible dietary plan, and when this is combined with regular exercise, will show dramatic weight loss results.

 

You need to lose the weight now. You need to get healthier, better looking, and happier. Talk with your doctor about the different options available to you.

 

 

Keep RIMONABANT in the original container and keep the container closed. Store it in a dry place at room temperature.

 

Do not give your RIMONABANT capsules to anyone else. It has been prescribed only for you. Keep RIMONABANT and all medications out of the reach of children.